Schonfeld Strategic Advisors LLC Agenus Inc Transaction History

Schonfeld Strategic Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.12 - $1.88 $9,971 - $16,737	-8,903 Reduced 38.42%	14,269 $16,000
Q2 2023 Aug 14, 2023	BUY	$1.31 - $2.04 $30,355 - $47,270	23,172 New	23,172 $37,000
Q4 2022 Feb 14, 2023	BUY	$2.02 - $3.25 $94,738 - $152,425	46,900 New	46,900 $112,000
Q1 2022 May 16, 2022	SELL	$2.35 - $3.47 $49,350 - $72,870	-21,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.92 - $5.74 $16,880 - $33,182	-5,781 Reduced 21.59%	21,000 $67,000
Q3 2021 Nov 16, 2021	BUY	$4.98 - $6.63 $133,369 - $177,558	26,781 New	26,781 $141,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.